semaglutide and surgery With Even More Powerful GLP-1s on the Horizon, Plastic Surgeons Are Upping the Body Contouring Game for Ozempic Patients Weight loss drugs may significantly

PMID: 40573323

Reports include serious side effects such as nausea, vomiting, and even hospitalization due to incorrect dosing and mislabeled products

Safety and efficacy of IDegLira titrated once weekly versus twice weekly in patients with type 2 diabetes uncontrolled on oral antidiabetic drugs: DUAL VI randomized clinical trial

SPARC preserves endothelial glycocalyx integrity, and protects against adverse cardiac inflammation and injury during viral myocarditis

Bone health in adults with obesity before and after interventions to promote weight loss

Reddys Laboratories Ltd., a global pharmaceutical company, today announced the launch of its injectable semaglutide under the brand name Obeda, marking an important step in expanding access to advanced GLP1 receptor agonistbased therapy for the management of type 2 diabetes in India